Bifidobacterium Market Size - By Product Type (Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Infantis, Bifidobacterium Animalis, Bifidobacterium Lactis), Application, End Use, Distribution Channel & Global Forecast, 2023 – 2032

Bifidobacterium Market Size

Bifidobacterium Market size was valued at USD 700 million in 2022 and is predicted to grow at a CAGR of 8% between 2023 and 2032. The rising consumer knowledge about the significance of maintaining a healthy gut is propelling the demand for probiotic products. Bifidobacterium is popular due to its ability to support digestive health and enhance the gut microbiota balance, augmenting the demand for products with this particular strain.
 

Consumers are also rapidly embracing a proactive approach to maintain their health and seeking preventive measures. Bifidobacterium can provide diverse health benefits including strengthening of the immune system, improvement in nutrient absorption, and promotion of the overall individual well-being, expanding the product demand.
 

Bifidobacterium provides numerous other health benefits beyond digestive health such as improvement in immune function, reduction in inflammation, mental health support, and maintenance of skin health. Scientific research has also highlighted these benefits, which is enhancing the bifidobacterium market demand.
 

The probiotic market, which comprises bifidobacterium products, is subject to various regulations & guidelines that pertain to labeling, health claims, safety, and efficacy requirements. Adherence to these regulations can be complicated and time-consuming. Extensive research, testing, and documentation must be carried out to meet the regulatory requirements of different regions. It is quite a challenge to maintain the viability & stability of Bifidobacterium strains through the product shelf life.
 

These bacteria are susceptible to environmental conditions such as temperature, humidity, and oxygen exposure. Proper storage, packaging, and transportation practices should be guaranteed to maintain the viability & effectiveness of Bifidobacterium strains. This can be a daunting task as Bifidobacterium strains have specific requirements for growth & survival. It is also difficult to formulate products that offer an optimal environment for Bifidobacterium growth & activity. These risks associated with Bifidobacterium may lower the adoption rates, further impeding market growth.
 

COVID-19 Impact

The global pandemic led to supply chain disruptions across various industries including the Bifidobacterium market. Constraints on international trade, transport disruptions, and manpower shortages triggered production delays, distribution issues, and a series of challenges in sourcing raw materials. These disturbances affected the availability & supply of Bifidobacterium products.
 

Bifidobacterium Market Trends

The overall demand for probiotic products including those containing Bifidobacterium has been gradually growing. Consumers are acknowledging the potential health benefits of probiotics, particularly for gut health and immune support. The market growth can thus be attributed to this increasing demand as more consumers are seeking out probiotic supplements as well as functional food & beverages. Many consumers are adopting personalized nutrition to support their dietary needs. This trend is also influencing the industry growth with an added stress on customized probiotic solutions. Companies are looking to customize Bifidobacterium-based products to meet individual health goals, satisfy the gut microbiota composition, and adhere to precise health conditions.
 

Bifidobacterium Market Analysis

The bifidobacterium market from bacterium longum segment held over USD 32.12 billion revenue in 2022. Bifidobacterium longum can support & promote gut health along with maintaining a healthy balance of gut microbiota, supporting digestion, and contributing to the holistic wellness of the gastrointestinal system. Bifidobacterium longum has been researched for its potential immune-modulating properties. It is believed to enhance immune response along with contributing to a healthy immune system. Bifidobacterium longum is often considered a vital element in specific product formulations such as probiotic supplements, functional foods, and infant formula.
 

The dietary supplements segment accounted for 40% of the bifidobacterium market share in 2022. The rising consumer focus on preventive health & wellness is propelling the intake of dietary supplements for the overall well-being of the consumer as well as specific health benefits. The growing focus on maintaining a healthy gut microbiome and digestive health is driving the demand for Bifidobacterium-based probiotic supplements. The increasing customer inclination toward organic & alternate health solutions is propelling advancements in Bifidobacterium-based pharmaceutical & nutraceutical formulations. The rising concentration on animal health & welfare is enhancing the demand for probiotic feed additives in animal nutrition.
 

The bifidobacterium market from adults segment is estimated to register a CAGR of 7.6% through 2032. The growing acknowledgment of the role of gut microbiota in infant health & development is encouraging the inclusion of Bifidobacterium strains in infant formulae and baby food products. The focus on enhancing gut health as well as improving the overall well-being of livestock & poultry is leading to the integration of Bifidobacterium strains into animal feed formulations.
 

The bifidobacterium market from online retail segment is set to continue growing in the coming years. The rising popularity of e-commerce platforms as well as the increase in online shopping are delivering consumers convenient ways to access Bifidobacterium supplements & probiotics. There is a level of trust & credibility associated with the purchasing of Bifidobacterium products from pharmacies and drugstores as these outlets are considered trustworthy sources of health-related products.
 

The U.S. bifidobacterium market was reached USD 38.34 billion revenue in 2022. The elderly population in North America is more aware of maintaining a healthy lifestyle owing to which they are often seeking dietary supplements to support their overall health. Bifidobacterium strains are normally used in probiotic supplements to promote digestive health and immune functions in aged adults. North America has a well-developed retail infrastructure with numerous supermarkets, health food stores, pharmacies, and online platforms offering a wide range of Bifidobacterium products. The convenient access to Bifidobacterium supplements & probiotics via various retail channels is also contributing to the market demand.
 

Bifidobacterium Market Share

Major companies operating in the bifidobacterium market are

• DuPont de Nemours, Inc.
• Chr. Hansen Holding A/S
• Lallemand Inc.
• Kerry Group
• Probi AB
• Morinaga Milk Industry Co., Ltd.
• Yakult Honsha Co., Ltd.
• Nestlé S.A.
• Danone S.A.
• Bifodan A/S.

These companies concentrate on strategic partnerships, new product launches, and commercialization efforts for market expansion. They are also heavily investing in research & development to introduce innovative products and garner the maximum market revenue.
 

Bifidobacterium Industry News

• In January 2023, in an effort to leverage on understanding of the gut-brain axis and meet customer demand for IBS-specific products, Nissin Foods Group, a producer of cup noodles in Japan, produced foods with function claims (FFCs) that include lactic acid bacteria for the first time. Bifidobacterium N61 and N708 tablets were two of the new FFCs that were made available. The first claims to lessen stomachaches, while the second was developed to improve memory and focus.
   

This bifidobacterium market research report includes in-depth coverage of the industry, with estimates & forecast in terms of revenue (USD Million) & volume (Kilo Tons) from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Bifidobacterium longum
• Bifidobacterium breve
• Bifidobacterium infantis
• Bifidobacterium animalis
• Bifidobacterium lactis
• Other Bifidobacterium strains

Market, By Application

• Dietary supplements
• Functional food & beverages
• Animal feed
• Pharmaceuticals
• Others

Market, By End Use

• Adults
• Children
• Infants
• Animals

Market, By Distribution Channel

• Online retail
• Supermarkets
• Health stores
• Pharmacies & drugstores
• Others

The above information has been provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Malaysia 
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt